- Email: [email protected]
Important Announcement Regarding Journal CME Articles
566 Rogers and Avram
J AM ACAD DERMATOL OCTOBER 2008
176. Yu W, Naim JO, McGowan M, Ippolito K, Lanzafame RJ. Photomodulation of oxidative metabolism and electron chain enzymes in rat liver mitochondria. Photochem Photobiol 1997;66:866-71. 177. Satino JL, Markou M. Hair regrowth and increased hair tensile strength using the HairMax LaserComb for low-level laser therapy. Intl J Cosmet Surg Aesthet Dermatol 2003;5:113-7. 178. Avram MR, Leonard RT Jr, Epstein ES, Williams JL, Bauman AJ. The current role of laser/light sources in the treatment of male and female pattern hair loss. J Cosmet Laser Ther 2007; 9:27-8. 179. Habib FK, Ross M, Ho CK, Lyons V, Chapman K. Serenoa repens (Permixon) inhibits the 5-alpha-reductase activity of human prostate cancer cell lines without interfering with PSA expression. Int J Cancer 2005;114:190-4. 180. Wilt T, Ishani A, MacDonald R. Serenoa repens for benign prostatic hyperplasia. Cochrane Database Syst Rev 2002;3: CD001423. 181. Bent S, Kane C, Shinohara K, Neuhaus J, Hudes ES, Goldberg H, et al. Saw palmetto for benign prostatic hyperplasia. N Engl J Med 2006;354:557-66. 182. Prager N, Bickett K, French N, Marcovici G. A randomized, double-blind, placebo-controlled trial to determine the effectiveness of botanically derived inhibitors of 5-alphareductase in the treatment of androgenetic alopecia. J Altern Complement Med 2002;8:143-52. 183. Colombo VE, Gerber F, Bronhofer M, Floersheim GL. Treatment of brittle fingernails and onychoschizia with biotin: scanning electron microscopy. J Am Acad Dermatol 1990; 23(6 Pt 1):1127-32.
184. Limat A, Suormala T, Hunziker T, Waelti ER, Braathen LR, Baumgartner R. Proliferation and differentiation of cultured human follicular keratinocytes are not influenced by biotin. Arch Dermatol Res 1996;288:31-8. 185. Nioxin web site. Available at: www.nioxin.com. Accessed July 15, 2008. 186. Procerin web site. Available at: www.procerin.com. Accessed July 15, 2008. 187. Tricomin web site. Available at: www.tricomin.com. Accessed July15, 2008. 188. Pyo HK, Yoo HG, Won CH, Lee SH, Kang YJ, Eun HC, et al. The effect of tripeptide-copper complex on human hair growth in vitro. Arch Pharm Res 2007;30:834-9. 189. Trachy RE, Fors TD, Pickart L, Uno H. The hair folliclestimulating properties of peptide copper complexes. Results in C3H mice. Ann NY Acad Sci 1991;642:468-9. 190. Toppik web site. Available at: www.toppik.com. Accessed July 15, 2008. 191. Khandpur S, Suman M, Reddy BS. Comparative efficacy of various treatment regimens for androgenetic alopecia in men. J Dermatol 2002;29:489-98. 192. Diani AR, Mulholland MJ, Shull KL, Kubicek MF, Johnson GA, Schostarez HJ, et al. Hair growth effects of oral administration of finasteride, a steroid 5-alpha reductase inhibitor, alone and in combination with topical minoxidil in the balding stump-tail macaque. J Clin Endocrinol Metab 1992; 74:345-50. 193. Tosti A, Iorizzo M, Vincenzi C. Finasteride treatment may not prevent telogen effluvium after minoxidil withdrawal. Arch Dermatol 2003;139:1221-2.
J AM ACAD DERMATOL OCTOBER 2008
176. Yu W, Naim JO, McGowan M, Ippolito K, Lanzafame RJ. Photomodulation of oxidative metabolism and electron chain enzymes in rat liver mitochondria. Photochem Photobiol 1997;66:866-71. 177. Satino JL, Markou M. Hair regrowth and increased hair tensile strength using the HairMax LaserComb for low-level laser therapy. Intl J Cosmet Surg Aesthet Dermatol 2003;5:113-7. 178. Avram MR, Leonard RT Jr, Epstein ES, Williams JL, Bauman AJ. The current role of laser/light sources in the treatment of male and female pattern hair loss. J Cosmet Laser Ther 2007; 9:27-8. 179. Habib FK, Ross M, Ho CK, Lyons V, Chapman K. Serenoa repens (Permixon) inhibits the 5-alpha-reductase activity of human prostate cancer cell lines without interfering with PSA expression. Int J Cancer 2005;114:190-4. 180. Wilt T, Ishani A, MacDonald R. Serenoa repens for benign prostatic hyperplasia. Cochrane Database Syst Rev 2002;3: CD001423. 181. Bent S, Kane C, Shinohara K, Neuhaus J, Hudes ES, Goldberg H, et al. Saw palmetto for benign prostatic hyperplasia. N Engl J Med 2006;354:557-66. 182. Prager N, Bickett K, French N, Marcovici G. A randomized, double-blind, placebo-controlled trial to determine the effectiveness of botanically derived inhibitors of 5-alphareductase in the treatment of androgenetic alopecia. J Altern Complement Med 2002;8:143-52. 183. Colombo VE, Gerber F, Bronhofer M, Floersheim GL. Treatment of brittle fingernails and onychoschizia with biotin: scanning electron microscopy. J Am Acad Dermatol 1990; 23(6 Pt 1):1127-32.
184. Limat A, Suormala T, Hunziker T, Waelti ER, Braathen LR, Baumgartner R. Proliferation and differentiation of cultured human follicular keratinocytes are not influenced by biotin. Arch Dermatol Res 1996;288:31-8. 185. Nioxin web site. Available at: www.nioxin.com. Accessed July 15, 2008. 186. Procerin web site. Available at: www.procerin.com. Accessed July 15, 2008. 187. Tricomin web site. Available at: www.tricomin.com. Accessed July15, 2008. 188. Pyo HK, Yoo HG, Won CH, Lee SH, Kang YJ, Eun HC, et al. The effect of tripeptide-copper complex on human hair growth in vitro. Arch Pharm Res 2007;30:834-9. 189. Trachy RE, Fors TD, Pickart L, Uno H. The hair folliclestimulating properties of peptide copper complexes. Results in C3H mice. Ann NY Acad Sci 1991;642:468-9. 190. Toppik web site. Available at: www.toppik.com. Accessed July 15, 2008. 191. Khandpur S, Suman M, Reddy BS. Comparative efficacy of various treatment regimens for androgenetic alopecia in men. J Dermatol 2002;29:489-98. 192. Diani AR, Mulholland MJ, Shull KL, Kubicek MF, Johnson GA, Schostarez HJ, et al. Hair growth effects of oral administration of finasteride, a steroid 5-alpha reductase inhibitor, alone and in combination with topical minoxidil in the balding stump-tail macaque. J Clin Endocrinol Metab 1992; 74:345-50. 193. Tosti A, Iorizzo M, Vincenzi C. Finasteride treatment may not prevent telogen effluvium after minoxidil withdrawal. Arch Dermatol 2003;139:1221-2.